v3.25.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash Flows From Operating Activities:    
Net loss $ (8,979,381) $ (10,417,704)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 189,056 165,735
Dividend and interest income (623,801) (569,068)
Stock-based compensation 2,812,566 7,782,967
Non-cash lease expense 151,447 90,313
Gain on exchange of warrants (1,711,698)
Change in fair value of warrant liabilities (97,188) (3,997,780)
Changes in operating assets and liabilities:    
Accounts receivable (169,100) (3,300)
Prepaid expenses and other current assets 33,591 57,851
Accounts payable 293,680 18,487
Accrued expenses and other current liabilities 32,799 581,616
Lease liability (162,317) (139,328)
Net Cash Used In Operating Activities (8,230,346) (6,430,211)
Cash Flows From Investing Activities:    
Sale of marketable securities 21,508,641 20,964,373
Purchase of marketable securities (20,887,923) (17,541,287)
Purchases of equipment (106,189) (171,043)
Net Cash Provided By Investing Activities 514,529 3,252,043
Cash Flows From Financing Activities:    
Net proceeds from issuance of common stock in at-the-market offering 494,783
Net proceeds from issuance of common stock in direct-offering 1,853,990
Proceeds from exchange and issuance of warrants, net [1] 7,528,027
Deferred offering costs (148,697)
Net Cash Provided By Financing Activities 7,379,330 2,348,773
Net Decrease In Cash and Cash Equivalents (336,487) (829,395)
Cash and Cash Equivalents - Beginning of the Year 884,377 1,713,772
Cash and Cash Equivalents - End of the Year 547,890 884,377
Supplemental Disclosures of Cash Flow Information:    
Interest
Income taxes
Non-cash investing and financing activities:    
Issuance of common stock held in abeyance 15
Return and cancellation of shares in lieu of payroll tax withholding $ 48,410 $ 39,308
[1] Includes gross proceeds of $8,123,391, less issuance costs of $595,364.

Source

10-K XBRL Zip